|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
338485074 |
| 003 |
DE-627 |
| 005 |
20230427041748.0 |
| 007 |
tu |
| 008 |
011228s2001 gw ||||| 00| ||ger c |
| 015 |
|
|
|a 02,N02,0436
|2 dnb
|
| 016 |
7 |
|
|a 963291629
|2 DE-101
|
| 020 |
|
|
|a 3936142114
|c brosch. : EUR 20.00, sfr 30.00
|9 3-936142-11-4
|
| 035 |
|
|
|a (DE-627)338485074
|
| 035 |
|
|
|a (DE-599)GBV338485074
|
| 035 |
|
|
|a (OCoLC)76348245
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a ger
|
| 044 |
|
|
|c XA-DE
|c XA-LV
|c XA-IT
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 44.78
|2 bkl
|
| 245 |
1 |
0 |
|a Wege zur Aufklärung der Therapieresistenz bei Erkrankungen durch HIV-Infektion: virale und zelluläre Faktoren
|c J. Cinatl ... (Hrsg.)
|
| 264 |
|
1 |
|a Lengerich [u.a.]
|b Pabst
|c 2001
|
| 300 |
|
|
|a 237 S
|b Ill., graph. Darst
|c 21 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 505 |
8 |
0 |
|a Literaturangaben
|
| 655 |
|
7 |
|a Aufsatzsammlung
|0 (DE-588)4143413-4
|0 (DE-627)105605727
|0 (DE-576)209726091
|2 gnd-content
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4203852-2
|0 (DE-627)105147915
|0 (DE-576)210157976
|a HIV-Infektion
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4143180-7
|0 (DE-627)104321458
|0 (DE-576)209724277
|a Arzneimittelresistenz
|2 gnd
|
| 689 |
0 |
|
|5 DE-101
|
| 700 |
1 |
|
|a Cinatl, Jindrich
|4 oth
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/hbz/toc/ht013501003.pdf
|m V:DE-605
|q pdf/application
|v 2008-11-15
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_74
|
| 912 |
|
|
|a ISIL_DE-354
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 936 |
b |
k |
|a 44.78
|j Immunkrankheiten
|0 (DE-627)10640945X
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 74
|1 01
|x 0354
|b 57497170X
|c 00
|f Magazin
|d R 21.0508
|e u
|j --%%--
|y z
|z 29-01-03
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a HIV Infections-complications
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 01
|a Drug Resistance
|
| 983 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a WC 503.2
|
| 984 |
|
|
|2 74
|1 01
|x 0354
|a 354$12214035
|
| 985 |
|
|
|2 74
|1 01
|x 0354
|a MD 4113
|
